[Hyderabad, April 30th, 2025] – The global clinical nutrition market is experiencing a significant surge, projected to grow from USD 52.4 billion in 2023 to USD 89.7 billion by 2031, expanding at a CAGR of 6.9% ClearView Market Insights, 2024. This expansion is driven by increasing demand across three key sectors:

Request Sample @ https://clearviewmarketinsights.com/report-details/global-clinical-nutrition-market/

Aging Population and Chronic Diseases:

·       Cancer Care: Specialized enteral nutrition products improve treatment tolerance, reducing hospital stays by up to 20%.

·       Diabetes Management: Tailored formulas help regulate glycemic response, reducing HbA1c levels by an average of 1.2%.

·       Geriatric Nutrition: Multinutrient supplements with muscle-preserving proteins slow sarcopenia progression by 30%.

Pediatric and Neonatal Nutrition:

·       Preterm Infant Care: Human milk fortifiers enriched with DHA and ARA increase survival rates by 12%.

·       Food Allergy Solutions: Hypoallergenic infant formulas are projected to see a 9.5% CAGR through 2030, driven by rising food sensitivity cases.

·       Malnutrition Eradication: UNICEF-supported programs integrating ready-to-use therapeutic foods (RUTFs) aim to cut global child wasting rates by 25% by 2027.

Personalized and Precision Nutrition:

·       Genetic Nutrition Profiling: Companies like Nutrigenomix offer DNA-based dietary recommendations improving treatment adherence by 40%.

·       Microbiome-Targeted Formulas: Synbiotic supplements enhance gut health, with clinical trials showing 20% faster recovery post-antibiotic use.

·       AI-Powered Meal Planning: Digital platforms design real-time diet adjustments based on continuous glucose monitoring (CGM) data.

2024 Breakthroughs

Commercialisation Milestones

Innovation Company Impact:

·       Plant-Based Clinical Nutrition Nestlé Health Science 15% growth in dairy-free medical nutrition demand

·       Microbiome Therapeutics Viome Launch of gut-targeted personalized supplements for cancer recovery

·       3D-Printed Nutritional Solutions Fit3D Customizable supplements for ICU patients, improving nutrient absorption rates by 25%

Investment & R&D Trends:

·       Startup Funding: USD 2.8 billion raised in 2023, led by personalized nutrition and gut health startups.

Corporate R&D:

·       Nestlé Health Science: USD 600M investment in microbiome therapies

·       Abbott Laboratories: Expansion of precision nutrition portfolio with AI-integrated platforms

Executive Insights:

·       "Precision nutrition will revolutionize patient care, allowing interventions that are truly individualized at the genetic and microbiome level."
— Dr. Sophia Martinez, Chief Medical Officer, Abbott Nutrition

·       "Clinical nutrition is no longer about just feeding patients—it's a front-line therapy against disease progression and hospital readmissions."
— Prof. David Liu, Harvard Medical School, Department of Nutrition

Regional Analysis

·       North America (XX% Market Share)

·       Medicaid and Medicare reforms expanding nutrition coverage in oncology and chronic care management.

·       Major hospital chains integrating personalized nutrition protocols to reduce readmissions.

·       Europe (30% Share)

·       EU Medical Device Regulation (MDR) expands definition of clinical nutrition products, enhancing regulatory oversight.

·       Rising elderly population drives demand for enteral feeding solutions, especially in Germany, France, and Italy.

·       Asia-Pacific (22% Share)

·       China’s Healthy China 2030 Initiative promoting hospital nutrition programs.

·       India’s government mandates nutrition support as part of public health insurance schemes.

Future Roadmap:

·       2025: Mainstream adoption of microbiome-based clinical nutrition in oncology treatment pathways.

·       2027: AI-driven predictive models for hospital malnutrition risk launched across top U.S. and EU hospitals.

·       2030: Full integration of personalized nutrition into electronic health records (EHRs) enabling real-time therapeutic adjustments.

Company Spotlight

·       Nestlé Health Science:

·       Market Position: 19% share in global clinical nutrition market.

·       2024 Innovation: Launch of plant-based enteral feeding solutions for chronic care settings.

·       Growth Strategy: Strategic acquisitions of microbiome and personalized nutrition startups.

Abbott Laboratories

·       Breakthrough: CGM-integrated nutrition planning for diabetes management.

·       Partnerships: Collaboration with Dexcom and Medtronic for AI-based dietary management tools.

For more insights, visit https://clearviewmarketinsights.com/report-store

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-736